ACAD 8-K 2026-01-13

ACADIA PHARMACEUTICALS INC (ACAD) 8-K dated 2026-01-13 — accession 0001193125-26-011706. This URL is the filing, not the ACAD hub.

ACADIA PHARMACEUTICALS INC (ACAD) is a biotechnology company listed on US.

ACADIA PHARMACEUTICALS INC filed a 8-K on 2026-01-13. Accession 0001193125-26-011706.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ACAD revenue for 2025-12-31 was $1.07B. Net income was $391.0M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. ACAD currently screens at market cap $3.51B.

Not investment advice. The ACAD SEC hub lists recent forms. The stock page is the research view.